SkinBioTherapeutics (SBTX) Competitors GBX 16.42 +0.18 (+1.08%) As of 09/12/2025 11:35 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesBuy This Stock SBTX vs. CIR, 4BB, BVXP, TILS, VSN, SCLP, MPH, HVO, ORPH, and REDXShould you be buying SkinBioTherapeutics stock or one of its competitors? The main competitors of SkinBioTherapeutics include Circassia Group (CIR), 4basebio (4BB), Bioventix (BVXP), Tiziana Life Sciences (TILS), Verseon (VSN), Scancell (SCLP), Mereo BioPharma Group plc (MPH.L) (MPH), hVIVO (HVO), Open Orphan (ORPH), and Redx Pharma (REDX). These companies are all part of the "biotechnology" industry. SkinBioTherapeutics vs. Its Competitors Circassia Group 4basebio Bioventix Tiziana Life Sciences Verseon Scancell Mereo BioPharma Group plc (MPH.L) hVIVO Open Orphan Redx Pharma SkinBioTherapeutics (LON:SBTX) and Circassia Group (LON:CIR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, media sentiment, institutional ownership, profitability, earnings and risk. Do institutionals and insiders believe in SBTX or CIR? 2.3% of SkinBioTherapeutics shares are owned by institutional investors. 2.7% of SkinBioTherapeutics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Does the media favor SBTX or CIR? In the previous week, SkinBioTherapeutics' average media sentiment score of 0.00 equaled Circassia Group'saverage media sentiment score. Company Overall Sentiment SkinBioTherapeutics Neutral Circassia Group Neutral Is SBTX or CIR more profitable? Circassia Group has a net margin of 0.00% compared to SkinBioTherapeutics' net margin of -237.95%. Circassia Group's return on equity of 0.00% beat SkinBioTherapeutics' return on equity.Company Net Margins Return on Equity Return on Assets SkinBioTherapeutics-237.95% -115.86% -61.18% Circassia Group N/A N/A N/A Which has higher earnings and valuation, SBTX or CIR? Circassia Group has higher revenue and earnings than SkinBioTherapeutics. SkinBioTherapeutics is trading at a lower price-to-earnings ratio than Circassia Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSkinBioTherapeutics£2.68M15.87-£3.71M-£0.01-1,314.00Circassia Group£27.90M0.00N/A£0.01N/A SummaryCircassia Group beats SkinBioTherapeutics on 6 of the 8 factors compared between the two stocks. Get SkinBioTherapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for SBTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SBTX vs. The Competition Export to ExcelMetricSkinBioTherapeuticsBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£42.50M£236.97M£5.87B£2.58BDividend YieldN/A3.78%5.68%5.30%P/E Ratio-1,314.0041.0874.525,410.88Price / Sales15.874,990.70517.4496,691.88Price / Cash9.0013.1937.5627.93Price / Book9.78103.7512.167.76Net Income-£3.71M-£90.99M£3.28B£5.89B7 Day Performance9.50%2.70%0.87%6.49%1 Month Performance7.43%21.05%4.96%55.92%1 Year Performance30.36%530.95%60.75%147.82% SkinBioTherapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SBTXSkinBioTherapeuticsN/AGBX 16.43+1.1%N/A+31.4%£42.50M£2.68M-1,314.0011CIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap Down4BB4basebioN/AGBX 885flatGBX 1,600+80.8%-39.5%£137.04M£933K-941.49101BVXPBioventixN/AGBX 2,428-1.3%N/A-36.5%£126.86M£13.66M1,639.2112TILSTiziana Life SciencesN/AN/AN/AN/A£113.85M-£3.60M-3.5911VSNVerseonN/AN/AN/AN/A£112.24MN/A-5.17N/AGap UpSCLPScancellN/AGBX 8.87-1.4%N/A-43.0%£92.09MN/A-426.6351News CoverageEarnings ReportHigh Trading VolumeMPHMereo BioPharma Group plc (MPH.L)N/AN/AN/AN/A£89.76MN/A-0.2150Gap DownHVOhVIVO1.8108 of 5 starsGBX 10.10+1.0%GBX 28+177.2%-66.3%£69.41M£62.73M651.61N/ANews CoverageORPHOpen OrphanN/AN/AN/AN/A£67.09M£34.71M-25.30179REDXRedx PharmaN/AN/AN/AN/A£58.35M£4.20M-150.00101Gap UpHigh Trading Volume Related Companies and Tools Related Companies Circassia Group Alternatives 4basebio Alternatives Bioventix Alternatives Tiziana Life Sciences Alternatives Verseon Alternatives Scancell Alternatives Mereo BioPharma Group plc (MPH.L) Alternatives hVIVO Alternatives Open Orphan Alternatives Redx Pharma Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:SBTX) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SkinBioTherapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share SkinBioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
